Identification of a type 1 diabetes-associated T cell receptor repertoire signature from the human peripheral blood
Puneet RawatiD, Melanie R. ShapiroiD, Leeana D. PetersiD, Michael WidrichiD, Koshlan Mayer-BlackwelliD, Keshav MotwaniiD, Milena PavlovićiD, Ghadi al Hajj, Amanda L. PosgaiiD, Chakravarthi KanduriiD, Giulio IsacchiniiD, Maria ChernigovskayaiD, Lonneke SchefferiD, Kartik MotwaniiD, Leandro Octavio Balzano-NogueiraiD, Camryn M. Pettenger-WilleyiD, Sebastiaan ValkiersiD, Laura M. JacobseniD, Michael J. HalleriD, Desmond SchatziD, Clive Henry WasserfalliD, Ryan O. Emerson, Andrew J. Fiore-GartlandiD, Mark A. AtkinsoniD, Gnter Klambauer, , Todd M. BruskoiD
Abstract
Type 1 Diabetes (T1D) is a T-cell mediated disease with a strong immunogenetic HLA dependence. HLA allelic influence on the T cell receptor (TCR) repertoire shapes thymic selection and controls activation of diabetogenic clones, yet remains largely unresolved in T1D. We sequenced the circulating TCR{beta} chain repertoire from 2250 HLA-typed individuals across three cross-sectional cohorts, including T1D patients, and healthy related and unrelated controls. We found that HLA risk alleles show higher restriction of TCR repertoires in T1D individuals. We leveraged deep learning to identify T1D-associated TCR subsequence motifs that were also observed in independent TCR cohorts residing in pancreas-draining lymph nodes of T1D individuals. Collectively, our data demonstrate T1D-related TCR motif enrichment based on genetic risk, offering a potential metric for autoreactivity and basis for TCR-based diagnostics and therapeutics.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 10
- FWCI
- 39.56
- Field percentile
- top 1%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- HLA class II mediates type 1 diabetes risk by anti-insulin repertoire selection
Arcadio Rubio García, Athina Paterou, … Marcin Ł. Pękalski·bioRxiv·Sep 6, 2021
- Genetic discovery and risk prediction for type 1 diabetes in individuals without high-risk HLA-DR3/DR4 haplotypes
Carolyn McGrail, Joshua Chiou, … Kyle J. Gaulton·Diabetes CarePeer-reviewed·Dec 3, 2024
- Autoimmune interactions between the HLA-DQβ157 polymorphism, T cell receptors, and microbial mimics of insulin in type 1 diabetes
Arcadio Rubio García, Athina Paterou, … Marcin Ł. Pękalski·medRxiv·May 11, 2022
- HLA-focused type 1 diabetes genetic risk prediction in populations of diverse ancestry
Dominika A. Michalek, Courtney Tern, … Stephen S. Rich·DiabetologiaPeer-reviewed·Oct 2, 2025
- Genetic association of T1D stratified by HLA DR3 and DR4 status reveals heterogeneity in pathways of progression to T1D
Amber M Luckett, Carolyn McGrail, … Kyle J. Gaulton·medRxiv·Aug 13, 2025
- Polymorphisms in Intron 1 of HLA-DRA Differentially Associate with Type 1 Diabetes and Celiac Disease and Implicate Involvement of Complement System Genes C4A and C4B
Özkan Aydemir, Jeffrey A. Bailey, … TEDDY Study Group·eLifePeer-reviewed·Feb 2, 2026